Skip to content

Contribution LUS in the Diagnosis of Acute Heart Failure (AHF) in Patients Admitted to the ED

Contribution of Pulmonary Ultrasonography in the Diagnosis of Acute Heart Failure (AHF) in Patients Admitted to Emergency Department (ED) for Dyspnea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03717779
Enrollment
600
Registered
2018-10-24
Start date
2016-01-02
Completion date
2017-10-01
Last updated
2019-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspnea; Cardiac

Keywords

Lung ultrasound,, heart failure, diagnosis, accuracy

Brief summary

This study assesses the potential of lung ultrasonography to diagnose heart failure.

Detailed description

Dyspnea is one of the most distressing situations for the patient . Emergency cases do not always present in conditions that are ideal for immediate diagnosis, which sometimes compromises outcome. Physical examination, laboratory findings and radiography are imperfect, resulting in a need for sophisticated test results that delay management. Lung ultrasonography is becoming a standard tool in critical cases in the ED. the investigators aim to perform ultrasonography on consecutive patients admitted to the ICU with dyspnea, comparing lung ultrasonography results on initial presentation with the final diagnosis by the ICU team. Three items were assessed: artifacts (horizontal A lines or vertical B lines indicating interstitial syndrome), lung sliding, and alveolar consolidation and/or pleural effusion, these items were grouped to assess ultrasound profiles. This study assesses the potential of lung ultrasonography to diagnose heart failure.

Interventions

DIAGNOSTIC_TESTlung ultrasound

we perform a lung ultrasound to all the patients admitted for dyspnea independantly from the final diagnosis

Sponsors

University of Monastir
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* non traumatic dyspnea with the final diagnosis of heart failure

Exclusion criteria

* coma, * shock,Mechanical Ventilation, * vasopressor drugs * arrhythmia serious and sustained, * non consent

Design outcomes

Primary

MeasureTime frameDescription
the accuracy of LUS in the diagnosis of heart failure0 daysthe accuracy of LUS in the diagnosis of heart failure measured by sensitivity ,specificity, and area under the roc curve

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026